Table 4.
LBM, TFM, and VO2max before and after treatment
| Placebo (n = 5) | GH (n = 5) | T (n = 6) | GHT (n = 5) | |
|---|---|---|---|---|
| LBM (kg) | ||||
| Baseline | 53.2 (2.8) | 55.7 (2) | 53.8 (1.9) | 58 (2.1) |
| 26 wk | 53.2 (2.9) | 57.2 (2.7) | 54.4 (2.3) | 59.3 (2) |
| Change | 0.0 | +1.4 (3.4) | +0.6 (3) | +1.3 (3) |
| P value compared with placebo | 0.37 | 0.64 | 0.52 | |
| TFM (kg) | ||||
| Baseline | 20.8 (2.7) | 19.4 (2.3) | 20.1 (2) | 22.2 (4) |
| 26 wk | 20.4 (2.7) | 18.2 (1.4) | 19.4 (1.8) | 18.6 (4.3) |
| Change | −0.3 (3.9) | −1.1 (2.7) | −0.6 (2.7) | −3.6 (5.9) |
| P value compared with placebo | 0.46 | 0.81 | 0.01 | |
| VO2max (ml/kg·min−1) | ||||
| Baseline | 23.5 (4) | 26.1 (1.3) | 24.6 (1.2) | 23.1 (1.5) |
| 26 wk | 25.6 (4) | 28.1 (2.4) | 26 (1.2) | 29.4 (2.5) |
| Change | +2 (6) | +1.9 (2) | +1.4 (1.7) | +6.3 (3) |
| P value compared with placebo | 0.97 | 0.81 | 0.03 |
All values are presented as mean (se). n, Number of participants who completed 6 months.